查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1790389

周邊動脈疾病市場規模、佔有率和趨勢分析報告：按設備類型、解剖部位、最終用途、地區和細分市場預測，2025 年至 2033 年

Peripheral Artery Disease Market Size, Share & Trends Analysis Report By Services (Endovascular Devices, Surgical Devices), By Anatomical Site (Aortoiliac, Femoropopliteal), By End-use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 90 Pages | 商品交期: 2-10個工作天內

價格

周邊動脈疾病市場概況

2024 年全球周邊動脈疾病市場規模估計為 73 億美元，預計到 2033 年將達到 113 億美元，2025 年至 2033 年的複合年成長率為 5.2%。疾病負擔增加、技術持續進步和人口老化等相互影響的力量正在推動周邊動脈疾病(PAD) 產業的發展。

未滿足的臨床需求與不斷發展的治療能力的融合將推動整個醫療保健領域的需求。糖尿病和菸草的日益普及仍然是推動市場發展的根本力量。這兩個風險因素都直接導致動脈粥狀硬化的進展，而動脈粥狀硬化是周邊動脈疾病 (PAD) 的核心病理機制。全球糖尿病的盛行率呈上升趨勢，尤其是在都市區老化社會中，吸菸在低收入國家仍然普遍存在，這進一步加劇了周邊動脈疾病 (PAD) 盛行率的持續上升。

2025年3月在ACC會議上發表的一項Intermountain Health研究發現，在有症狀的周邊動脈疾病患者中，僅有29.6%的女性和33.5%的男性接受了指引指導的治療。在追蹤的7,522例患者中，死亡率超過50%，顯示診斷和治療方面存在嚴重差距。儘管發病率相似，但女性獲得最佳治療的可能性較低。這項研究強調了改善篩檢通訊協定和更有針對性的周邊動脈疾病（PAD）管理方法的必要性。

血管內治療技術的快速創新正在重塑治療策略並推動市場發展。藥物塗層球囊、動脈粥狀硬化斑塊切除術系統和生物可吸收支架等新一代工具可提高療效、減少併發症並縮短恢復時間。這些解決方案因能精準治療複雜病變，同時減少血管再阻塞和再次手術的需要而日益受到青睞。 2025 年 3 月，《科學報告》發表的一項研究介紹了 DBMedDet，這是一種深度學習模型，可提高血管內治療期間支架置入的準確性。憑藉高精度（mAP 0.841）和即時檢測（127 FPS），該模型在識別冠狀動脈、周邊和腦血管病例中的支架邊界方面優於 YOLO 模型。

人口老化進一步擴大了周邊動脈疾病 (PAD) 干預措施的市場潛力，65 歲及以上人口面臨的風險顯著增加。與老齡化相關的動脈僵硬和合併症的累積使這一人群尤為脆弱。 2025 年 3 月，《日誌雜誌》發表了一項「長壽家族研究」的結果，該研究顯示長壽個體患外周動脈疾病 (PAD) 的風險顯著降低。這些家族後代的周邊動脈疾病 (PAD) 盛行率僅為 1%，而預期盛行率為 12%。調查團隊將這些結果與保護性遺傳特徵和更健康的血管特徵聯繫起來，並確定了四個可能與周邊動脈疾病 (PAD) 抗性相關的基因組區域。

目錄

第1章調查方法與範圍

第2章執行摘要

3. 全球周邊動脈疾病市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 周邊動脈疾病市場分析工具
    • 產業分析—波特五力分析
    • PESTEL分析

第4章周邊動脈疾病市場：依設備類型估計與趨勢分析

  • 周邊動脈疾病市場：設備類型儀表板
  • 周邊動脈疾病市場：設備類型變化分析
  • 周邊動脈疾病市場規模、預測和趨勢分析（按設備類型，2021-2033 年）
  • 血管內設備
  • 手術設備

第5章周邊動脈疾病市場：依解剖部位進行的估計與趨勢分析

  • 周邊動脈疾病市場：解剖區域儀表板
  • 周邊動脈疾病市場：解剖變異分析
  • 周邊動脈疾病市場規模、預測和趨勢分析（按解剖部位，2021-2033 年）
  • 主髂動脈
  • 股膕肌
  • 脛骨

第6章周邊動脈疾病市場：按最終用途的估計和趨勢分析

  • 周邊動脈疾病市場：最終用途儀表板
  • 周邊動脈疾病市場：最終用途差異分析
  • 周邊動脈疾病市場規模、預測和趨勢分析（按最終用途，2021-2033 年）
  • 醫院
  • 門診設施
  • 其他

第7章周邊動脈疾病市場：按國家、設備類型、解剖部位和最終用途分類的估計和趨勢分析

  • 全球周邊動脈疾病市場：區域儀表板
  • 2021-2033年市場規模與預測趨勢分析
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 瑞典
    • 挪威
    • 丹麥
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭態勢

  • 主要製造商的近期趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商格局
    • 主要經銷商和通路合作夥伴名單
    • 2024年主要企業市場佔有率分析
    • BD
    • Bentley InnoMed
    • Scitech Medical
    • Abbott Laboratories
    • Boston Scientific Corporation
    • WL Gore & Associates, Inc.
    • Medtronic
    • Cook
    • Terumo Corporation
    • iVascular
    • Getinge AB
    • BIoTronik SE & Co KG
Product Code: GVR-4-68040-660-5

Peripheral Artery Disease Market Summary

The global peripheral artery disease market size was estimated at USD 7.3 billion in 2024 and is projected to reach USD 11.3 billion by 2033, growing at a CAGR of 5.2% from 2025 to 2033. The intersecting forces of rising disease burden, continuous technological advancement, and demographic aging drive the peripheral artery disease (PAD) industry.

This alignment of unmet clinical needs with evolving therapeutic capabilities accelerates demand across care settings. The growing prevalence of diabetes and tobacco use remains a foundational force driving the market. Both risk factors contribute directly to the progression of atherosclerosis, the core pathological mechanism behind PAD. With diabetes rates climbing globally-particularly in aging, urban populations-and smoking still widespread in lower-income countries, the incidence of PAD continues to rise.

In March 2025, an Intermountain Health study presented at the ACC conference revealed that only 29.6% of women and 33.5% of men with symptomatic peripheral artery disease received full guideline-directed therapy. Among 7,522 patients tracked, the mortality rate exceeded 50%, underscoring severe gaps in diagnosis and treatment. Despite similar referral rates, women were less likely to receive optimal care. The study emphasized the need for improved screening protocols and focused PAD management.

Rapid innovation in endovascular technologies is reshaping treatment strategies and reinforcing market momentum. Next-generation tools such as drug-coated balloons, atherectomy systems, and bioresorbable stents offer improved efficacy, fewer complications, and shorter recovery times. These solutions are increasingly favored for treating complex lesions precisely while reducing restenosis and the need for repeat interventions. In March 2025, a study in Scientific Reports introduced DBMedDet, a deep-learning model that improved stent placement accuracy during endovascular procedures. With high precision (mAP 0.841) and real-time detection (127 FPS), it outperformed YOLO models in identifying stent boundaries across coronary, peripheral, and cerebrovascular cases.

Population aging further amplifies the market potential for PAD interventions, with individuals over 65 facing significantly elevated risk. Age-related arterial stiffening and the accumulation of comorbidities make this demographic especially vulnerable. In March 2025, the Aging Journal published findings from the Long Life Family Study showing individuals from long-lived families have a significantly lower risk of PAD. PAD prevalence among offspring of these families was only 1%, versus an expected 12%. Researchers linked this to protective genetic traits and healthier vascular profiles, identifying four genomic regions potentially tied to PAD resistance.

Global Peripheral Artery Disease Market Report Segmentation

This report forecasts revenue growth at global, regional & country levels and provides an analysis of the industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global peripheral artery disease market report based on device type, anatomical site, end use, and region:

  • Device Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Endovascular Devices
  • Surgical Devices
  • Anatomical Site Outlook (Revenue, USD Million, 2021 - 2033)
  • Aortoiliac
  • Femoropopliteal
  • Tibial
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Outpatient Facilities
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Device Type
    • 1.2.2. Anatomical Site
    • 1.2.3. End Use
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecast timeline.
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity price analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Device Type Segment
    • 2.2.2. Anatomical Site Segment
    • 2.2.3. End Use Segment
    • 2.2.4. Regional Outlook
  • 2.3. Competitive Insights

Chapter 3. Global Peripheral Artery Disease Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising prevalence of diabetes and smoking
      • 3.2.1.2. Advancements in endovascular technologies
      • 3.2.1.3. Growing elderly population and PAD risk
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost of advanced revascularization procedures
      • 3.2.2.2. Limited access to PAD treatment in low-income regions
  • 3.3. Peripheral Artery Disease Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Peripheral Artery Disease Market: Device Type Estimates & Trend Analysis

  • 4.1. Peripheral Artery Disease Market: Device Type Dashboard
  • 4.2. Peripheral Artery Disease Market: Device Type Movement Analysis
  • 4.3. Peripheral Artery Disease Market Size & Forecasts and Trend Analysis, by Device Type, 2021 - 2033 (USD Million)
  • 4.4. Endovascular Devices
    • 4.4.1. Market estimates and forecast, 2021 - 2033 (USD Million)
  • 4.5. Surgical Devices
    • 4.5.1. Market estimates and forecast, 2021 - 2033 (USD Million)

Chapter 5. Peripheral Artery Disease Market: Anatomical Site Estimates & Trend Analysis

  • 5.1. Peripheral Artery Disease Market: Anatomical Site Dashboard
  • 5.2. Peripheral Artery Disease Market: Anatomical Site Movement Analysis
  • 5.3. Peripheral Artery Disease Market Size & Forecasts and Trend Analysis, by Anatomical Site, 2021 - 2033 (USD Million)
  • 5.4. Aortoiliac
    • 5.4.1. Market estimates and forecast, 2021 - 2033 (USD Million)
  • 5.5. Femoropopliteal
    • 5.5.1. Market estimates and forecast, 2021 - 2033 (USD Million)
  • 5.6. Tibial
    • 5.6.1. Market estimates and forecast, 2021 - 2033 (USD Million)

Chapter 6. Peripheral Artery Disease Market: End Use Estimates & Trend Analysis

  • 6.1. Peripheral Artery Disease Market: End Use Dashboard
  • 6.2. Peripheral Artery Disease Market: End Use Movement Analysis
  • 6.3. Peripheral Artery Disease Market Size & Forecasts and Trend Analysis, by End Use, 2021 - 2033 (USD Million)
  • 6.4. Hospitals
    • 6.4.1. Market estimates and forecast, 2021 - 2033 (USD Million)
  • 6.5. Outpatient Facilities
    • 6.5.1. Market estimates and forecast, 2021 - 2033 (USD Million)
  • 6.6. Others
    • 6.6.1. Market estimates and forecast, 2021 - 2033 (USD Million)

Chapter 7. Peripheral Artery Disease Market: Regional Estimates & Trend Analysis by Country, Device Type, Anatomical Site & End Use

  • 7.1. Global Peripheral Artery Disease Market: Regional Dashboard
  • 7.2. Market Size & Forecasts Trend Analysis, 2021 - 2033
  • 7.3. North America
    • 7.3.1. Market Estimates and Forecasts 2021 - 2033 (USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Regulatory framework/ reimbursement structure
      • 7.3.2.3. Competitive scenario
      • 7.3.2.4. U.S. market estimates and forecast, 2021 - 2033 (USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Key country dynamics
      • 7.3.3.2. Regulatory framework/ reimbursement structure
      • 7.3.3.3. Competitive scenario
      • 7.3.3.4. Canada market estimates and forecast, 2021 - 2033 (USD Million)
    • 7.3.4. Mexico
      • 7.3.4.1. Key country dynamics
      • 7.3.4.2. Regulatory framework/ reimbursement structure
      • 7.3.4.3. Competitive scenario
      • 7.3.4.4. Mexico market estimates and forecast, 2021 - 2033 (USD Million)
  • 7.4. Europe
    • 7.4.1. Market Estimates and Forecasts 2021 - 2033 (USD Million)
    • 7.4.2. UK
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework/ reimbursement structure
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. UK market estimates and forecast, 2021 - 2033 (USD Million)
    • 7.4.3. Germany
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework/ reimbursement structure
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. Germany market estimates and forecast, 2021 - 2033 (USD Million)
    • 7.4.4. France
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Regulatory framework/ reimbursement structure
      • 7.4.4.3. Competitive scenario
      • 7.4.4.4. France market estimates and forecast, 2021 - 2033 (USD Million)
    • 7.4.5. Italy
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Regulatory framework/ reimbursement structure
      • 7.4.5.3. Competitive scenario
      • 7.4.5.4. Italy market estimates and forecast, 2021 - 2033 (USD Million)
    • 7.4.6. Spain
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Regulatory framework/ reimbursement structure
      • 7.4.6.3. Competitive scenario
      • 7.4.6.4. Spain market estimates and forecast, 2021 - 2033 (USD Million)
    • 7.4.7. Sweden
      • 7.4.7.1. Key country dynamics
      • 7.4.7.2. Regulatory framework/ reimbursement structure
      • 7.4.7.3. Competitive scenario
      • 7.4.7.4. Sweden market estimates and forecast, 2021 - 2033 (USD Million)
    • 7.4.8. Norway
      • 7.4.8.1. Key country dynamics
      • 7.4.8.2. Regulatory framework/ reimbursement structure
      • 7.4.8.3. Competitive scenario
      • 7.4.8.4. Norway market estimates and forecast, 2021 - 2033 (USD Million)
    • 7.4.9. Denmark
      • 7.4.9.1. Key country dynamics
      • 7.4.9.2. Regulatory framework/ reimbursement structure
      • 7.4.9.3. Competitive scenario
      • 7.4.9.4. Denmark market estimates and forecast, 2021 - 2033 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Market Estimates and Forecasts 2021 - 2033 (USD Million)
    • 7.5.2. China
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. China market estimates and forecast, 2021 - 2033 (USD Million)
    • 7.5.3. Japan
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. Japan market estimates and forecast, 2021 - 2033 (USD Million)
    • 7.5.4. India
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework/ reimbursement structure
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. India market estimates and forecast, 2021 - 2033 (USD Million)
    • 7.5.5. Australia
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework/ reimbursement structure
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. Australia market estimates and forecast, 2021 - 2033 (USD Million)
    • 7.5.6. Thailand
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework/ reimbursement structure
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Thailand market estimates and forecast, 2021 - 2033 (USD Million)
    • 7.5.7. South Korea
      • 7.5.7.1. Key country dynamics
      • 7.5.7.2. Regulatory framework/ reimbursement structure
      • 7.5.7.3. Competitive scenario
      • 7.5.7.4. South Korea market estimates and forecast, 2021 - 2033 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Market Estimates and Forecasts 2021 - 2033 (USD Million)
    • 7.6.2. Brazil
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Brazil market estimates and forecast, 2021 - 2033 (USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework/ reimbursement structure
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. Argentina market estimates and forecast, 2021 - 2033 (USD Million)
  • 7.7. MEA
    • 7.7.1. Market Estimates and Forecasts 2021 - 2033 (USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Saudi Arabia market estimates and forecast, 2021 - 2033 (USD Million)
    • 7.7.3. South Africa
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. South Africa market estimates and forecast, 2021 - 2033 (USD Million)
    • 7.7.4. UAE
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. UAE market estimates and forecast, 2021 - 2033 (USD Million)
    • 7.7.5. Kuwait
      • 7.7.5.1. Key country dynamics
      • 7.7.5.2. Regulatory framework/ reimbursement structure
      • 7.7.5.3. Competitive scenario
      • 7.7.5.4. Kuwait market estimates and forecast, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Manufacturers
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2024
    • 8.3.4. BD
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Bentley InnoMed
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Scitech Medical
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Abbott Laboratories
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Boston Scientific Corporation
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. W. L. Gore & Associates, Inc.
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Medtronic
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. Cook
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Product benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. Terumo Corporation
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Product benchmarking
      • 8.3.12.4. Strategic initiatives
    • 8.3.13. iVascular
      • 8.3.13.1. Company overview
      • 8.3.13.2. Financial performance
      • 8.3.13.3. Product benchmarking
      • 8.3.13.4. Strategic initiatives
    • 8.3.14. Getinge AB
      • 8.3.14.1. Company overview
      • 8.3.14.2. Financial performance
      • 8.3.14.3. Product benchmarking
      • 8.3.14.4. Strategic initiatives
    • 8.3.15. Biotronik SE & Co KG
      • 8.3.15.1. Company overview
      • 8.3.15.2. Financial performance
      • 8.3.15.3. Product benchmarking
      • 8.3.15.4. Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviation
  • Table 3 Global peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
  • Table 4 Global peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million
  • Table 5 Global peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
  • Table 6 Global peripheral artery disease market, by region, 2021 - 2033 (USD Million)
  • Table 7 North America peripheral artery disease market, by country, 2021 - 2033 (USD Million)
  • Table 8 North America peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
  • Table 9 North America peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
  • Table 10 North America peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
  • Table 11 U.S. peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
  • Table 12 U.S. peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
  • Table 13 U.S. peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
  • Table 14 Canada peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
  • Table 15 Canada peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
  • Table 16 Canada peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
  • Table 17 Mexico peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
  • Table 18 Mexico peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
  • Table 19 Mexico peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
  • Table 20 Europe peripheral artery disease market, by country, 2021 - 2033 (USD Million)
  • Table 21 Europe peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
  • Table 22 Europe peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
  • Table 23 Europe peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
  • Table 24 UK peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
  • Table 25 UK peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
  • Table 26 UK peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
  • Table 27 Germany peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
  • Table 28 Germany peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
  • Table 29 Germany peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
  • Table 30 France peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
  • Table 31 France peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
  • Table 32 France peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
  • Table 33 Italy peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
  • Table 34 Italy peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
  • Table 35 Italy peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
  • Table 36 Spain peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
  • Table 37 Spain peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
  • Table 38 Spain peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
  • Table 39 Denmark peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
  • Table 40 Denmark peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
  • Table 41 Denmark peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
  • Table 42 Sweden peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
  • Table 43 Sweden peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
  • Table 44 Sweden peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
  • Table 45 Norway peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
  • Table 46 Norway peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
  • Table 47 Norway peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
  • Table 48 Asia Pacific peripheral artery disease market, by country, 2021 - 2033 (USD Million)
  • Table 49 Asia Pacific peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
  • Table 50 Asia Pacific peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
  • Table 51 Asia Pacific peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
  • Table 52 Japan peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
  • Table 53 Japan peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
  • Table 54 Japan peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
  • Table 55 China peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
  • Table 56 China peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
  • Table 57 China peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
  • Table 58 India peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
  • Table 59 India peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
  • Table 60 India peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
  • Table 61 Australia peripheral artery disease market, by country, 2021 - 2033 (USD Million)
  • Table 62 Australia peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
  • Table 63 Australia peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
  • Table 64 Australia peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
  • Table 65 Thailand peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
  • Table 66 Thailand peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
  • Table 67 Thailand peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
  • Table 68 South Korea peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
  • Table 69 South Korea peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
  • Table 70 South Korea peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
  • Table 71 Latin America peripheral artery disease market, by country, 2021 - 2033 (USD Million)
  • Table 72 Latin America peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
  • Table 73 Latin America peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
  • Table 74 Latin America peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
  • Table 75 Brazil peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
  • Table 76 Brazil peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
  • Table 77 Brazil peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
  • Table 78 Argentina peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
  • Table 79 Argentina peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
  • Table 80 Argentina peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
  • Table 81 MEA peripheral artery disease market, by country, 2021 - 2033 (USD Million)
  • Table 82 MEA peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
  • Table 83 MEA peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
  • Table 84 MEA peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
  • Table 85 South Africa peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
  • Table 86 South Africa peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
  • Table 87 South Africa peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
  • Table 88 Saudi Arabia peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
  • Table 89 Saudi Arabia peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
  • Table 90 Saudi Arabia peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
  • Table 91 UAE peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
  • Table 92 UAE peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
  • Table 93 UAE peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
  • Table 94 Kuwait peripheral artery disease market, by device type, 2021 - 2033 (USD Million)
  • Table 95 Kuwait peripheral artery disease market, by anatomical site, 2021 - 2033 (USD Million)
  • Table 96 Kuwait peripheral artery disease market, by end use, 2021 - 2033 (USD Million)
  • Table 97 Participant's overview
  • Table 98 Financial performance
  • Table 99 Key companies undergoing expansions
  • Table 100 Key companies undergoing acquisitions
  • Table 101 Key companies undergoing collaborations
  • Table 102 Key companies launching new products
  • Table 103 Key companies undergoing partnerships
  • Table 104 Key companies undertaking other strategies

List of Figures

  • Fig. 1 Peripheral artery disease market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain-based sizing & forecasting
  • Fig. 7 QFD modelling for market share assessment
  • Fig. 8 Peripheral artery disease market revenues, 2024 (USD Millions)
  • Fig. 9 Market driver relevance analysis (Current & future impact)
  • Fig. 10 Market restraint relevance analysis (Current & future impact)
  • Fig. 11 Porter's five forces analysis
  • Fig. 12 PESTLE analysis
  • Fig. 13 Peripheral artery disease market Device type outlook:
  • Fig. 14 Peripheral artery disease market: Device type movement analysis
  • Fig. 15 Segment dashboard
  • Fig. 16 Global endovascular devices market, 2021 - 2033 (USD Million)
  • Fig. 17 Global surgical devices market, 2021 - 2033 (USD Million)
  • Fig. 18 Peripheral artery disease market Anatomical site outlook:
  • Fig. 19 Peripheral artery disease market: Anatomical site movement analysis
  • Fig. 20 Global aortoiliac market, 2021 - 2033 (USD Million)
  • Fig. 21 Global femoropopliteal market, 2021 - 2033 (USD Million)
  • Fig. 22 Global tibial market, 2021 - 2033 (USD Million)
  • Fig. 23 Peripheral artery disease market end use outlook:
  • Fig. 24 Peripheral artery disease market: end use movement analysis
  • Fig. 25 Global hospitals market, 2021 - 2033 (USD Million)
  • Fig. 26 Global outpatient facilities market, 2021 - 2033 (USD Million)
  • Fig. 27 Global others market, 2021 - 2033 (USD Million)
  • Fig. 28 Regional marketplace: Key takeaways
  • Fig. 29 North America peripheral artery disease market, 2021 - 2033 (USD Million)
  • Fig. 30 U.S. peripheral artery disease market, 2021 - 2033 (USD Million)
  • Fig. 31 Canada peripheral artery disease market, 2021 - 2033 (USD Million)
  • Fig. 32 Mexico peripheral artery disease market, 2021 - 2033 (USD Million)
  • Fig. 33 Europe peripheral artery disease market, 2021 - 2033 (USD Million)
  • Fig. 34 Germany peripheral artery disease market, 2021 - 2033 (USD Million)
  • Fig. 35 UK peripheral artery disease market, 2021 - 2033 (USD Million)
  • Fig. 36 France peripheral artery disease market, 2021 - 2033 (USD Million)
  • Fig. 37 Italy peripheral artery disease market, 2021 - 2033 (USD Million)
  • Fig. 38 Spain peripheral artery disease market, 2021 - 2033 (USD Million)
  • Fig. 39 Sweden peripheral artery disease market, 2021 - 2033 (USD Million)
  • Fig. 40 Denmark peripheral artery disease market, 2021 - 2033 (USD Million)
  • Fig. 41 Norway peripheral artery disease market, 2021 - 2033 (USD Million)
  • Fig. 42 Asia Pacific peripheral artery disease market, 2021 - 2033 (USD Million)
  • Fig. 43 Japan peripheral artery disease market, 2021 - 2033 (USD Million)
  • Fig. 44 China peripheral artery disease market, 2021 - 2033 (USD Million)
  • Fig. 45 India peripheral artery disease market, 2021 - 2033 (USD Million)
  • Fig. 46 Australia peripheral artery disease market, 2021 - 2033 (USD Million)
  • Fig. 47 Thailand peripheral artery disease market, 2021 - 2033 (USD Million)
  • Fig. 48 South Korea peripheral artery disease market, 2021 - 2033 (USD Million)
  • Fig. 49 Latin America peripheral artery disease market, 2021 - 2033 (USD Million)
  • Fig. 50 Brazil peripheral artery disease market, 2021 - 2033 (USD Million)
  • Fig. 51 Argentina peripheral artery disease market, 2021 - 2033 (USD Million)
  • Fig. 52 MEA peripheral artery disease market, 2021 - 2033 (USD Million)
  • Fig. 53 South Africa peripheral artery disease market, 2021 - 2033 (USD Million)
  • Fig. 54 Saudi Arabia peripheral artery disease market, 2021 - 2033 (USD Million)
  • Fig. 55 UAE peripheral artery disease market, 2021 - 2033 (USD Million)
  • Fig. 56 Kuwait peripheral artery disease market, 2021 - 2033 (USD Million)
  • Fig. 57 Market Participant Categorization
  • Fig. 58 Strategy mapping